Furthermore, altered microbial metabolites, including SCFAs, seem to influence the expression of pro-inflammatory cytokines like IL-4, IL-5, and IL-13, which are hallmarks of AD [45]. This evidence concerns the gene IL13 and Alzheimer disease.